finance.yahoo.com / Yahoo! Finance
npub1vap…wc3n
2024-11-22 17:09:36
Author Public Key
npub1vap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aessgrwc3nSeen on
wss://articles.layer3.newsPublished at
2024-11-22 17:09:36Event JSON
{
"id": "8a072018dd436f87340f09264f4226037f58ada7bfd95b9a8b00f37c1809b647",
"pubkey": "6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"created_at": 1732295376,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/2-innovative-stocks-could-deliver-150000288.html"
],
[
"subject",
"2 Innovative Stocks That Could Deliver Outsize Returns"
],
[
"published_at",
"1732287600"
],
[
"image",
"https://media.zenfs.com/en/motleyfool.com/cceaba89b6ac20f0435f3c701b49562b"
],
[
"p",
"6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://media.zenfs.com/en/motleyfool.com/cceaba89b6ac20f0435f3c701b49562b"
],
[
"t",
"other:perspective"
],
[
"summary",
"Iovance Biotherapeutics is a cancer-focused biotech that develops therapies based on tumor-infiltrating lymphocytes (TILs). The company has received FDA approval for its first therapy, Amtagvi, and has a rich pipeline of new treatments. Recursion Pharmaceuticals is using artificial intelligence to develop drugs more efficiently and has several products in phase 2 studies. Both companies have significant upside potential, but also carry risk."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aesst3mr8r\nhttps://media.zenfs.com/en/motleyfool.com/cceaba89b6ac20f0435f3c701b49562b\n\nhttps://finance.yahoo.com/news/2-innovative-stocks-could-deliver-150000288.html",
"sig": "d3043e23f606d70307086d2275136af802fb69de7b292b2f6769c4abc71ea37ef79d85a442ac23b5f8a36c4b1798d2462a10879fcc21c15123ea4718dbd3ff13"
}